Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Retatrutide is still in clinical evaluation, and long-term data on combined use with MOTS-c is limited
Click here to contact KFF Health News' reporting team
Lv M, Xue G, Cheng H, Meng P, Lian X, Holscher C, et al
it's unknown whether these medicines cause thyroid C-cell tumors, including medullary thyroid carcinoma, in humans Applicable products are contraindicated if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Pregnancy, breastfeeding, plans to become pregnant, contraception, and the timing of treatment discontinuation should be discussed with your prescribing clinician, since instructions differ by medication
Thyroid disease (especially hypothyroidism)
US$ 25.04
US$ 29.78
US$ 29.52
US$ 20.35
US$ 23.65
US$ 25.57
US$ 26.10
US$ 29.18
US$ 26.20
US$ 27.23
US$ 24.44
US$ 20.94
US$ 20.96
